Crossmark

A phase I study of vorinostat combined with bortezomib in Japanese patients with relapsed or refractory multiple myeloma

Crossref DOI link: https://doi.org/10.1007/s12185-015-1897-7

Published Online: 2015-11-30

Published Print: 2016-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ogawa, Yoshiaki

Ogura, Michinori

Tobinai, Kensei

Ando, Kiyoshi

Suzuki, Tatsuya

Watanabe, Takashi

Ohmachi, Ken

Uchida, Toshiki

Hanson, Mary E.

Tanaka, Yoshinobu

Koh, Yasuhiro

Shimamoto, Takashi

Hotta, Tomomitsu
License Information

Text and Data Mining valid from 2015-11-30